StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap $5.72MP/E –Yield –

CollPlant Biotechnologies pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CollPlant Biotechnologies's pe ratio was 543.0× on Feb 28, 2023, against 7.7× a year earlier. Over the last 3 years it ranged from 1.9× to 561.0×, with a median of 3.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 2023543.0×+125.5
2022Dec 30, 2022417.5×+409.8
2020Feb 28, 20207.7×+3.7
2019Dec 31, 20194.0×+2.1
2018Dec 31, 20181.9×–

More CollPlant Biotechnologies figures

See a number that looks wrong?